| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01822756 Details | 2018-02-12 Interventional | 1 | 42 | Gemcitabine Paclitaxel Pancreatic Canc… Solid Tumors | Dose escalation ended after Cohort B1, RUX 10 mg BID - GCSF in October 2014. In October 2014, further enrollment of additional study cohorts was stopped; Part 2 of the study wasn't conducted. Pharmacokinetic and Pharmacodynamics analyses weren't performed due to early termination. Maximum tolerated dose (MTD) was not reached. | |||
| NCT01484041 Details | 2018-02-09 Interventional | 1/2 | 12 | Aromatase Inhib… Breast Neoplasm… Breast Cancer | Decision by company to cease development of dovitinib - | |||
| NCT01002248 Details | 2018-02-09 Interventional | 3 | [1 Refs] | 135 | Bortezomib Dexamethasone Multiple Myelom… Neoplasms, Plas… | - - | ||
| NCT00723918 Details | 2018-02-09 Interventional | 2 | 0 | Methadone Peripheral Nerv… Polyneuropathie… HIV-associated … Polyneuropathy | Withdrawal of pharmaceutical support from Novartis - no participants randomized - | |||
| NCT03325868 Details | 2018-02-08 Interventional | 4 | 0 | Ulipristal acet… Adenomyosis Dysmenorrhea Hemorrhage Uterine Hemorrh… Heavy Uterine B… | IND issues - | |||
| NCT01702909 Details | 2018-02-08 Interventional | 2 | 7 | Interleukin-2 Carcinoma, Rena… Kidney Neoplasm… Neoplasms Kidney Cancer M… Renal Cell Canc… | PI Decision - | |||
| NCT01279187 Details | 2018-02-07 Interventional | 2 | 27 | Teriparatide Implant | Study was terminated due to patient complications unrelated to study drugs - | |||
| NCT00491387 Details | 2018-02-07 Interventional | 4 | 24 | Metoprolol Hypertension | Adverse events reported with beta-blockers as primary therapy. Early termination due to a publication in the literature suggesting potential increased cardiac mortality in hypertensive patients treated primarily with beta blockers. Did not feel that continued treatment in volunteer subjects could be justified. | |||
| NCT03422874 Details | 2018-02-06 Interventional | 1 | 0 | Ixazomib Nelfinavir Lymphoma Neoplasms | Sponsor withdrew support - | |||
| NCT02736435 Details | 2018-02-06 Interventional | 3 | 0 | Leuprolide Leiomyoma Myofibroma Uterine Leiomyo… | Lengthy delays and inadequate support to proceed. - | |||
| NCT01882530 Details | 2018-02-06 Interventional | 4 | 223 | Acetaminophen Ketoprofen Morphine Nefopam Agnosia Post Operative … | Practice on postoperative pain management changed - | |||
| NCT01142323 Details | 2018-02-06 Interventional | 1/2 | 8 | Fenofibrate Cholangitis Cholangitis, Sc… Primary Scleros… | - - | |||
| NCT01668550 Details | 2018-02-05 Interventional | 1 | 43 | AZD-0424 Neoplasms Advanced Solid … | Single agent phase completed, insufficient supportive preclinical data to proceed with
combination phase - | |||
| NCT01636466 Details | 2018-02-05 Interventional | 3 | 1 | Everolimus Kidney Failure,… Renal Insuffici… | Feasibility - | |||
| NCT00095862 Details | 2018-02-05 Interventional | 1/2 | - | Cyclophosphamid… Interferon-alph… Interferons Breast Neoplasm… Breast Cancer Unspecified Adu… | - - | |||
| NCT02040909 2013-005572-17 Details | 2018-02-01 Interventional | 1 | 91 | Propofol Premature Birth Anesthesia Intu… Other Preterm I… Premature Birth… Propofol Overdo… | interim results concluded no added value of additional inclusion - | |||
| NCT01773616 Details | 2018-02-01 Interventional | 3 | 24 | Methylprednisol… Methylprednisol… Methylprednisol… Mycophenolic Ac… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Rituximab Lupus Erythemat… Lupus Nephritis Nephritis Systemic Lupus … | Study assessments for patients recruited continuing per protocol so patients receive a minimum
of 6 months follow up. No safety concerns have been raised. - | |||
| NCT01565590 Details | 2018-02-01 Interventional | 3 | 4 | Dexmedetomidine Propofol Hemorrhage Subarachnoid He… Subarachnoid He… | Slow enrollment along with new competing studies, investigators decided to stop study - | |||
| NCT02815059 Details | 2018-01-31 Interventional | 1 | 0 | Dasatinib Ibrutinib Prednisone Leukemia Leukemia, Lymph… Philadelphia Ch… Precursor Cell … Acute Lymphobla… | Termination of Investigator Initiated Studies using Ibrutinib - | |||
| NCT02488616 Details | 2018-01-31 Interventional | 2 | 0 | Hormones Insulin Insulin, Globin… Diabetes Mellit… Diabetes Mellit… Type 1 Diabetes | Medtronic support terminated - |